Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections

Antibiotic eye drops are being used before and after intravitreal injections. Currently there is no study indicating the benefit of there usage or their dosage.

In this study we compare the efficacy of Vigamox eye drops (antibiotic)starting 3 days prior to the injection versus 1 day prior to intravitreal injection.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Intravitreal Injection Patients Endophthalmitis Eye Diseases Eye Infections Infections Macular Degeneration Retinal Degeneration Retinal Diseases

Age range

21 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Illinois Retina Associates

Harvey, Illinois, 60426, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient who need intravitreal injections patients who are willing to participate in the study

Exclusion criteria

Patients who are allergic to Vigamox or who have taken any eye drops within the past 3 weeks

Treatment and study plan

Vigamox

Drug

eye drops 3 times day either 1 or 3 days prior to intravitreal injection

Primary outcomes

Timed study

Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Illinois Retina Associates

Other

Collaborators

Alcon Research

Registry information

Official study title

To Compare the Efficacy of Topical Vigamox Eye Drops at Tid 3 Days Prior to Intravitreal Injection Versus Tid 1 Day Prior to Intravitreal Injection

Important dates

Study start: 2008
Primary completion: 2011
Study completion: 2011
First posted: Jun 4, 2008
Registry last updated: Aug 7, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed